CAAS Capital Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-25,000
Closed -$249K 791
2021
Q3
$249K Buy
+25,000
New +$249K 0.01% 399